Penn Foundation

Penn Foundation

Services:
Assessment/Pre-treatment
• Screening for mental disorders
• Outreach to persons in the community
• Interim services for clients
• Screening for substance use
• Comprehensive substance use assessment
• Comprehensive mental health assessment

Gender Accepted

• Female
• Male

Payment/Insurance/Funding Accepted

• Cash or self-payment
• Medicaid
• Private health insurance
• State-financed health insurance plan other than Medicaid

Ancillary Services

• Case management service
• Social skills development

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Regular outpatient treatment
• Outpatient
• Intensive outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment

Language Services

• Sign language services for the deaf and hard of hearing

Type of Opioid Treatment

• Prescribes buprenorphine
• Prescribes naltrexone
• Accepts clients using MAT but prescribed elsewhere
• Buprenorphine maintenance
• Maintenance service with medically supervised withdrawal after stabilization
• Relapse prevention with naltrexone

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity
• In-network prescribing entity
• No formal relationship with prescribing entity

Transitional Services

• Outcome follow-up after discharge
• Aftercare/continuing care
• Discharge Planning
• Naloxone and overdose education

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment

External Opioid Medications Source

• Other contracted prescribing entity
• In-network prescribing entity
• No formal relationship with prescribing entity

Age Groups Accepted

• Young Adults
• Adults

License/Certification/Accreditation

• State Substance use treatment agency

Testing

• Breathalyzer or blood alcohol testing
• Drug and alcohol oral fluid testing
• TB screening
• Drug or alcohol urine screening

Recovery Support Services

• Housing services
• Mentoring/peer support
• Employment counseling or training
• Assistance with obtaining social services
• Self-help groups

Education and Counseling Services

• HIV or AIDS education, counseling, or support
• Family counseling
• Substance use disorder education
• Individual counseling
• Group counseling
• Health education services other than HIV/AIDS or hepatitis
• Hepatitis education, counseling, or support

Facility Smoking Policy

• Smoking permitted in designated area

Pharmacotherapies

• Clonidine
• Medication for mental disorders
• Naltrexone (oral)
• Nicotine replacement
• Buprenorphine with naloxone
• Buprenorphine (extended-release, injectable)
• Acamprosate (Campral®)
• Disulfiram
• Naltrexone (extended-release, injectable)
• Non-nicotine smoking/tobacco cessation
• Buprenorphine without naloxone

Facility Vaping Policy

• Vaping not permitted

Treatment Approaches

• 12-step facilitation
• Cognitive behavioral therapy
• Trauma-related counseling
• Relapse prevention
• Telemedicine/telehealth therapy
• Anger management
• Motivational interviewing
• Substance use disorder counseling

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder